Clinicians Comment on Controversial Mammography Study
Daniel B. Kopans, MD, Carol H. Lee, MD, and Edith A. Perez, MD, discuss the findings of a controversial study on screening mammograms.
Daniel B. Kopans, MD, Carol H. Lee, MD, and Edith A. Perez, MD, discuss the findings of a controversial study on screening mammograms.
One recently published study found no mortality benefit to annual screening mammograms, but critics cry “foul.”
Annual mammography does not reduce mortality from breast cancer among 40- to 59-year-old women.
Digital mammography screening with a direct radiography (DR) photon-counting system has good diagnostic performance.
Semiautomated computer-derived measurements of breast density are consistent with radiologist assessments.
A new prediction model has been developed that may quantify a woman’s risk of breast cancer more accurately.
Among 1,000 U.S. women screened annually for 10 years, 0.3 to 3.2 will avoid breast cancer death.
Due to ACA, more than 25.4 million Original Medicare beneficiaries received at least one free preventive service in 2013
Reviews show a substantial reduction in breast cancer mortality with screening.
Studies show promise for magnetic resonance guided focused ultrasound ablation and lower lymph node positivity with shorter time between mammography screening.